Related Experiment Video

Updated: Jun 12, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

A survey of chronic hepatitis B patient management practices in the European Union

T Berg1, Y Benhamou, J L Calleja

  • 1Sektion Hepatologie, Klinik für Gastroenterologie und Rheumatologie, Universitätsklinikum Leipzig, Leipzig, Germany. thomas.berg@medizin.uni-leipzig.de

Journal of Viral Hepatitis
|May 22, 2010
PubMed

Insights

This study surveyed European chronic hepatitis B virus (HBV) infection characteristics and management. Most patients were HBeAg-negative men with significant liver disease, with most receiving treatment.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Chronic hepatitis B virus (HBV) infection remains a significant global health concern.
  • Understanding the epidemiological characteristics and management practices of chronic HBV (CHB) is crucial for effective patient care.

Purpose of the Study:

  • To evaluate the clinical characteristics of CHB patients in the European Union.
  • To assess current management practices for CHB in European countries.

Main Methods:

  • A survey of physician practices and patient records was conducted in France, Germany, Italy, and Spain between July and October 2006.
  • Data were collected from 200 physicians and 2023 patients with CHB.

Main Results:

  • The majority of surveyed patients were men (69%), HBeAg-negative (64%), and presented with significant liver disease (53%).
  • Of 1665 HBV-monoinfected patients, 71% were receiving treatment.
  • Treatment initiation criteria included specific HBV DNA and ALT levels, varying between HBeAg-positive and HBeAg-negative patients.

Conclusions:

  • European CHB patients are predominantly HBeAg-negative males with advanced liver disease.
  • Management practices at treatment initiation were characterized by defined viral load and liver enzyme thresholds.

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...